Výsledky vyhledávání - "Yi‐Lan Zeng"

Akademický článek

The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive

Autor: Hong Zhao, Chi Zhang, Xian-Xiang Chen, Qi Zhu, Wen-Xiang Huang, Yi-Lan Zeng, Ying-Xia Liu, Guo-Jun Li, Wei-Jun Du, Jing Yao, Jia-Wen Li, Peng Peng, Gui-Qiang Wang

Publikováno v: Infectious Diseases of Poverty, Vol 10, Iss 1, Pp 1-10 (2021)

Abstract Background The management of discharge COVID-19 patients with recurrent positive SARS-CoV-2 RNA is challenging. However, there are fewer scientific dissertations about the risk of recurrent positive. The aim of this study was to explore the

Externí odkaz: https://doaj.org/article/16d28ca401d64ff996291efe63773fe1

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Analysis of Treatment of 3 Patients with Acute-on-Chronic Liver Failure

Autor: Jun Lei, Yi-lan Zeng, Lv-ye Xu, Ying Wang

Publikováno v: Case Reports in Medicine, Vol 2018 (2018)

Acute-on-chronic liver failure (ACLF) is an acute liver decompensation that occurs within 4 weeks on the basis of chronic liver disease. At present, the treatments of ACLF include general supportive treatment, etiological treatment, prevention and tr

Externí odkaz: https://doaj.org/article/c9b5b52d007c45a081f659f0263e9f64

Zobrazit plný text záznamu

Plný text ve formátu HTML

Real‐world study on HBsAg loss of combination therapy in HBeAg ‐negative chronic hepatitis B patients

Autor: Jun‐Hao Chu, Yan Huang, Dong‐Ying Xie, Hong Deng, Jia Wei, Yu‐Juan Guan, Guo‐Jun Li, Yi‐Lan Zeng, Jia‐Hong Yang, Xin‐Yue Chen, Jia Shang, Jia‐Bin Li, Na Gao, Zhi‐Liang Gao

Publikováno v: Journal of Viral Hepatitis. 29:765-776

Combination therapy with pegylated interferon (PEG-IFN) and nucleos(t)ide analogues (NAs) can enhance hepatitis B surface antigen (HBsAg) clearance. However, the specific treatment strategy and the patients who would benefit the most are unclear. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a90519ef72f06d4670b9f782f1ce2327
https://doi.org/10.1111/jvh.13722

Zobrazit plný text záznamu

Plný text ve formátu HTML

An-Luo-Hua-Xian Pill Can Improve the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated With Entecavir

Background & Aims: Chronic hepatitis B (CHB) can cause liver fibrosis and lead to cirrhosis even cancer, antiviral therapy can reverse liver fibrosis with limited effect, thus we aimed to evaluate the effect of An-Luo-Hua-Xian pill (ALHX) on fibrosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc2b1375ecc336dd31f1b51c8a9e7d1
https://doi.org/10.21203/rs.3.rs-1192811/v1

Zobrazit plný text záznamu

Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update

Publikováno v: Journal of Hepatology. 77:S838

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::55a532c073ca8c1ce6903c7a52a0ff1d
https://doi.org/10.1016/s0168-8278(22)01971-7

Zobrazit plný text záznamu

An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir

Publikováno v: Journal of Clinical and Translational Hepatology. :000-000

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::759c56a910553930956a89158a325fcb
https://doi.org/10.14218/jcth.2022.00091

Zobrazit plný text záznamu

The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive

Autor: Guo-Jun Li, Guiqiang Wang, Jiawen Li, Peng Peng, Wei-Jun Du, Hong Zhao, Ying-Xia Liu, Wen-Xiang Huang, Yi-Lan Zeng, Xianxiang Chen, Qi Zhu, Chi Zhang, Jing Yao

Publikováno v: Infectious Diseases of Poverty
Infectious Diseases of Poverty, Vol 10, Iss 1, Pp 1-10 (2021)

Background The management of discharge COVID-19 patients with recurrent positive SARS-CoV-2 RNA is challenging. However, there are fewer scientific dissertations about the risk of recurrent positive. The aim of this study was to explore the relations

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fef07f41bd7129ecb329a09b9062e504
http://europepmc.org/articles/PMC8010778

Zobrazit plný text záznamu

Functional cure based on pegylated interferon ? in long-term nucleoside analog suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest project in China), an interim report

Publikováno v: Journal of Hepatology. 73:S886-S887

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::75d01c1720da6a6efe66950fc6903389
https://doi.org/10.1016/s0168-8278(20)32210-8

Zobrazit plný text záznamu

Analysis of Treatment of 3 Patients with Acute-on-Chronic Liver Failure

Autor: Yi-lan Zeng, Ying Wang, Jun Lei, Lv-ye Xu

Publikováno v: Case Reports in Medicine
Case Reports in Medicine, Vol 2018 (2018)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d123b833a41d320a075483b2b9e04f22
http://europepmc.org/articles/PMC6282116

Zobrazit plný text záznamu

Factors Associated with Mother-to-child Transmission of Hepatitis B Virus Despite Immunoprophylaxis

Autor: Lan-Lan Chen, Cui-Ping Liu, Hong Tang, Li Wang, Yi-lan Zeng, Rong Hu, Min Zhou

Publikováno v: Internal Medicine. 54:711-716

OBJECTIVE: This study aimed to assess risk factors for mother-to-child transmission (MTCT) of hepatitis B virus (HBV) after immunoprophylaxis. METHODS: Risk factors for MTCT were assessed using a multivariate logistic regression model. PATIENTS: We e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46593b7b4f5eb43337defa159cfc2a8d
https://doi.org/10.2169/internalmedicine.54.3514

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání